Together with FyoniBio, a specialist in bioassay development and validation for analysis of clinical samples, BioGenes is offering services in the field of pharmacokinetic and immunogenicity testing. Recently, both companies have established a highly sensitive assay for detection of ADAs against an ASO. The antibodies for this project were generated by BioGenes, while FyoniBio set up the assay.
Please have a closer look at the findings of this immunogenicity project in this poster.